We’re on this Path Together
The combination of federal diabetes research funding and JDRF’s own investment has become one of the world’s most effective public-private partnerships focused on disease research. This partnership has yielded impressive research advances much faster than anyone believed possible a decade ago. We must build upon this momentum in research and continue leveraging this success, which is bringing us closer to a cure for type 1 diabetes and its complications. The Special Diabetes Program-funded research has led to new and better treatments, improved technologies, and a greater understanding of diabetes – all of which mean better lives for people with diabetes. A few of the top research findings that demonstrate a strong return on the federal investment are in the following areas: Research uncovering the causes of type 1 diabetes, preventing, treating, and reversing type 1 diabetes and complications.
It is JDRF’s top legislative priority for 2010: Renewing the Special Diabetes Program. This program is set to expire after Sept. 30, 2011. The program must be renewed this year to continue large-scale clinical trials and proactively plan next steps to maximize research opportunities and most effectively allocate research dollars.
Here is how you can help:
Become a JDRF advocate. Sign up at advocacy.jdrf.org, text ACTION to 56533, or visit our Facebook fan page at www.facebook.com/jdrfadvocacy.
